Stewart Graham Barker

Insider activity · 24 months2 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 1 buy · 0 salesFeb 26 · 1 buy · 1 saleMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 20 Feb 2026 for JB Chemicals & Pharmaceuticals Limited, €580k.

Filing timeline

BuySale

Stewart Graham Barker

Stewart Graham Barker: trading record in brief

Stewart Graham Barker is a declared insider of JB Chemicals & Pharmaceuticals Limited, with filings sourced from SEBI (PIT + SAST). Between 30 January 2026 and 19 February 2026, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 20 February 2026 came the latest disclosure, a share grant for €580k in JB Chemicals & Pharmaceuticals Limited. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.